Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bjørn Hoe"'
Autor:
Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris Neumann Nielsen, Natasha Chidekel Bergman, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens Juul Holst, Flemming Dela, Julie Overgaard, Joachim Størling, Tina Vilsbøll, Thomas Fremming Dejgaard, Jesper Foged Havelund, Vladimir Gorshkov, Frank Kjeldsen, Nils Joakim Færgeman, Martin Rønn Madsen, Mikkel B Christensen, Filip Krag Knop
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:3261-3274
Context Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to exert insulin-independent effects on lipid and bone metabolism. Objective We investigated the effects of a 6-day subcutaneous GIP infusion on circulating lipids, white ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b1e70e9927dfa7789868c4c86ddff5
https://doi.org/10.1210/clinem/dgac542
https://doi.org/10.1210/clinem/dgac542
Autor:
Tina Vilsbøll, Sebastian M. Nguyen Heimbürger, Filip K. Knop, Thomas F. Dejgaard, Jens J. Holst, Natasha C. Bergmann, Mikkel B. Christensen, Bjørn Hoe, Bolette Hartmann, Chris N Nielsen
Publikováno v:
Diabetologia. 64:2425-2431
Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect of exogenous glucose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b819d1617ec2e0f8f036de979bd7ebf4
https://doi.org/10.1007/s00125-021-05547-8
https://doi.org/10.1007/s00125-021-05547-8
Autor:
BJØRN HOE, MADS B. LYNGGAARD, LÆRKE S. GASBJERG, MADS M. HELSTED, SIGNE STENSEN, BOLETTE HARTMANN, JENS J. HOLST, MIKKEL B. CHRISTENSEN, TINA VILSBØLL, FILIP K. KNOP
Publikováno v:
Diabetes. 71
The insulinotropic effect of exogenous glucose-dependent insulinotropic polypeptide (GIP) is severely reduced or even absent in persons with type 2 diabetes but may be partly regained following improved glycemic control. Here, we examined the beta ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9442eee726e51c9be362a5970488e028
https://doi.org/10.2337/db22-357-or
https://doi.org/10.2337/db22-357-or
Autor:
Amalie R. Lanng, David S. Mathiesen, Mikkel B. Christensen, Mette M. Rosenkilde, Lærke S. Gasbjerg, Filip K. Knop, Signe Stensen, Emilie Johanning Bari, Bjørn Hoe, Bolette Hartmann, Jens J. Holst
Publikováno v:
Diabetes, Obesity and Metabolism. 23:68-74
The glucose-dependent insulinotropic polypeptide (GIP) fragment GIP(3-30)NH2 is a selective, competitive GIP receptor antagonist, and doses of 800 to 1200 pmol/kg/min inhibit GIP-induced potentiation of glucose-stimulated insulin secretion by >80% in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf607aefbb19f4a5c3d8c695820d5b5
https://doi.org/10.1111/dom.14186
https://doi.org/10.1111/dom.14186
Autor:
Joachim Størling, Bolette Hartmann, Charles Pyke, Tina Vilsbøll, Mikkel B. Christensen, Filip K. Knop, Anne Julie Overgaard, Chris N. Nielsen, Bjørn Hoe, Flemming Dela, Thomas F. Dejgaard, Sebastian M. Nguyen Heimbürger, Jens J. Holst
Publikováno v:
Diabetes. 70
Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to increase adipose tissue lipolysis (at low insulin levels), adipokine secretion and circulating levels of inflammation markers via the GIP receptor (GIPR) in adipose tissue. We in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f65741ec04b49f69bb0962c7e7f411e0
https://doi.org/10.2337/db21-107-or
https://doi.org/10.2337/db21-107-or
Autor:
Sebastian M N, Heimbürger, Bjørn, Hoe, Chris N, Nielsen, Natasha C, Bergmann, Bolette, Hartmann, Jens J, Holst, Tina, Vilsbøll, Thomas F, Dejgaard, Mikkel B, Christensen, Filip K, Knop
Publikováno v:
Diabetologia. 64(11)
Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect of exogenous glucose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::071ee5ab19c9108d13cdaa0ce5473770
https://pubmed.ncbi.nlm.nih.gov/34405256
https://pubmed.ncbi.nlm.nih.gov/34405256
Autor:
Jens J. Holst, David S. Mathiesen, Bolette Hartmann, Mette M. Rosenkilde, Signe Stensen, Amalie R. Lanng, Lærke S. Gasbjerg, Emilie Johanning Bari, Mikkel Christensen, Filip K. Knop, Bjørn Hoe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7e9421e4042306d1b04e1bc37916cff
https://doi.org/10.1111/dom.14186/v2/response1
https://doi.org/10.1111/dom.14186/v2/response1
Autor:
Bolette Hartmann, Filip K. Knop, Joachim Størling, Thomas F. Dejgaard, Natasha C. Bergmann, Tina Vilsbøll, Mikkel B. Christensen, Bjørn Hoe, Jens J. Holst, Chris N. Nielsen, Sebastian M. Nguyen Heimbürger
Publikováno v:
Diabetes. 69
The glucagonotropic effect of glucose-dependent insulinotropic polypeptide (GIP) during insulin-induced hypoglycemia in patients with type 1 diabetes (T1D) prompted us to investigate the effect of a 6-day subcutaneous (sc) GIP infusion on glucose var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14116ac180b59857b6b12c3fa5cfff94
https://doi.org/10.2337/db20-351-or
https://doi.org/10.2337/db20-351-or
Autor:
Tina Vilsbøll, Asger Lund, Mikkel B. Christensen, Susanne Engberg, Filip K. Knop, Sebastian M. Nguyen Heimbürger, Thomas F. Dejgaard, Jens J. Holst, Bolette Hartmann, Mads Bank Lynggaard, Lærke S. Gasbjerg, Bjørn Hoe
Publikováno v:
Diabetes. 69
Gluco-regulatory effects of the insulinotropic and glucagonotropic gut hormone glucose-dependent insulinotropic polypeptide (GIP) in type 1 diabetes (T1D) are unclear. We evaluated the effects of exogenous and endogenous GIP on plasma glucose excursi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::570339084058dc26773d79b111e89166
https://doi.org/10.2337/db20-89-lb
https://doi.org/10.2337/db20-89-lb
Autor:
Laerke Smidt, Gasbjerg, Emilie J, Bari, Signe, Stensen, Bjørn, Hoe, Amalie R, Lanng, David S, Mathiesen, Mikkel B, Christensen, Bolette, Hartmann, Jens J, Holst, Mette M, Rosenkilde, Filip Krag, Knop
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(1)
The glucose-dependent insulinotropic polypeptide (GIP) fragment GIP(3-30)NH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7309ffc93ebeababd39b53824e1bbfc0
https://pubmed.ncbi.nlm.nih.gov/32886401
https://pubmed.ncbi.nlm.nih.gov/32886401